Table 1 Baseline characteristics
Overall (n = 269) | |
|---|---|
Age, years | 65 ± 15 |
Sex | |
Male | 184 (68.4%) |
Female | 85 (31.6%) |
Height, cm | 162.4 ± 10.4 |
Weight, kg | 60.5 ± 17.4 |
APACHE II score | 28 ± 7.7 |
Admission type | |
Medical | 211 (78.4%) |
Elective surgery | 24 (8.9%) |
Emergency surgery | 34 (12.6%) |
Admission route | |
Ward | 113 (42.0%) |
Operation room | 52 (19.3%) |
Emergency room | 69 (25.7%) |
Other hospital | 35 (13.0%) |
Nafamostat mesylate dose, mg/h | 15.8 ± 8.8 |
Chronic medical condition | |
Hypertension | 163 (60.6%) |
Ischemic heart disease | 64 (23.8%) |
Diabetes mellitus | 35 (13.0%) |
Maintenance dialysis | 87 (32.3%) |
Heart failure | 11 (4.1%) |
Bleeding risk | 160 (59.5%) |
Creatinine at discharge, mg/dL | 3.57 ± 3.42 |
Nephrotoxic agents | 81 (30.1%) |
Filter clot | 167 (62.1%) |
Filter type | |
AN69ST | 74 (27.5%) |
CTA | 19 (7.1%) |
PS | 176 (65.4%) |